1. Home
  2. A vs EW Comparison

A vs EW Comparison

Compare A & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

N/A

Current Price

$119.90

Market Cap

39.8B

Sector

Industrials

ML Signal

N/A

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

N/A

Current Price

$85.10

Market Cap

46.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
A
EW
Founded
1999
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.8B
46.0B
IPO Year
1999
1999

Fundamental Metrics

Financial Performance
Metric
A
EW
Price
$119.90
$85.10
Analyst Decision
Buy
Buy
Analyst Count
16
21
Target Price
$165.13
$96.47
AVG Volume (30 Days)
1.9M
4.8M
Earning Date
05-27-2026
05-13-2026
Dividend Yield
0.82%
N/A
EPS Growth
3.16
N/A
EPS
4.57
1.83
Revenue
$4,472,000,000.00
$6,067,600,000.00
Revenue This Year
$8.03
$13.19
Revenue Next Year
$6.22
$9.81
P/E Ratio
$27.29
$49.94
Revenue Growth
6.43
11.55
52 Week Low
$96.43
$65.94
52 Week High
$160.27
$87.89

Technical Indicators

Market Signals
Indicator
A
EW
Relative Strength Index (RSI) 28.83 63.52
Support Level $115.37 $81.61
Resistance Level $123.79 $87.20
Average True Range (ATR) 3.37 2.39
MACD -0.27 0.92
Stochastic Oscillator 3.89 99.17

Price Performance

Historical Comparison
A
EW

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: